Alan Seth Krasner - Net Worth and Insider Trading

Alan Seth Krasner Net Worth

The estimated net worth of Alan Seth Krasner is at least $2 Million dollars as of 2024-04-26. Alan Seth Krasner is the Chief Medical Officer of Crinetics Pharmaceuticals Inc and owns about 43,210 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $2 Million. Details can be seen in Alan Seth Krasner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alan Seth Krasner has not made any transactions after 2023-10-17 and currently still holds the listed stock(s).

Transaction Summary of Alan Seth Krasner

To

Alan Seth Krasner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alan Seth Krasner owns 2 companies in total, including Crinetics Pharmaceuticals Inc (CRNX) , and Albireo Pharma Inc (ALBO) .

Click here to see the complete history of Alan Seth Krasner’s form 4 insider trades.

Insider Ownership Summary of Alan Seth Krasner

Ticker Comapny Transaction Date Type of Owner
CRNX Crinetics Pharmaceuticals Inc 2023-10-17 Chief Medical Officer
ALBO Albireo Pharma Inc 2012-09-30 Chief Medical Officer

Alan Seth Krasner Latest Holdings Summary

Alan Seth Krasner currently owns a total of 1 stock. Alan Seth Krasner owns 43,210 shares of Crinetics Pharmaceuticals Inc (CRNX) as of October 17, 2023, with a value of $2 Million.

Latest Holdings of Alan Seth Krasner

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRNX Crinetics Pharmaceuticals Inc 2023-10-17 43,210 42.12 1,820,005

Holding Weightings of Alan Seth Krasner


Alan Seth Krasner Form 4 Trading Tracker

According to the SEC Form 4 filings, Alan Seth Krasner has made a total of 2 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 7,000 shares on October 17, 2023, which brought Alan Seth Krasner around $210,000.

Insider Trading History of Alan Seth Krasner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alan Seth Krasner Trading Performance

GuruFocus tracks the stock performance after each of Alan Seth Krasner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan Seth Krasner is -0.57%. GuruFocus also compares Alan Seth Krasner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan Seth Krasner within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alan Seth Krasner's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alan Seth Krasner

Average Return

3.3%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 39.09 -0.57 3.3 -19.14 -4.4
Relative Return to S&P 500(%) 37.12 0.65 -2.94 -26.86 -19.94

Alan Seth Krasner Ownership Network

Ownership Network List of Alan Seth Krasner

No Data

Ownership Network Relation of Alan Seth Krasner


Alan Seth Krasner Owned Company Details

What does Crinetics Pharmaceuticals Inc do?

Who are the key executives at Crinetics Pharmaceuticals Inc?

Alan Seth Krasner is the Chief Medical Officer of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include Chief Development Officer Dana Pizzuti , director & See Remarks Richard Scott Struthers , and Chief Operating Officer Jeff E. Knight .

Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary

Over the past 18 months, Alan Seth Krasner made 1 insider transaction in Crinetics Pharmaceuticals Inc (CRNX) with a net sale of 7,000. Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 42,092 shares made by Stephen F. Betz , a net sale of 61,634 shares made by Dana Pizzuti , and a net sale of 340,951 shares made by Richard Scott Struthers .

In summary, during the past 3 months, insiders sold 187,216 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 187,216 shares. During the past 18 months, 619,400 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 614,400 shares.

Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Crinetics Pharmaceuticals Inc Insider Transactions

No Available Data

Alan Seth Krasner Mailing Address

Above is the net worth, insider trading, and ownership report for Alan Seth Krasner. You might contact Alan Seth Krasner via mailing address: C/o Crinetics Pharmaceuticals, Inc., 10222 Barnes Canyon Road, Bldg. #2, San Diego Ca 92121.

Discussions on Alan Seth Krasner

No discussions yet.